Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. - Wikidata - awgldk - TriplyDB

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

http://www.wikidata.org/entity/Q37087937

about

Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease Biomarkers of Renal Disease and Progression in Patients with Diabetes Advances in the use of multimarker panels for renal risk stratification Measurement of renal function in patients with chronic kidney disease Biomarkers in nephrology: Core Curriculum 2013 Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.Biomarkers in chronic kidney disease, from kidney function to kidney damage Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.Paediatric normative data for urine NGAL/creatinine ratio.Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.First evidence of subclinical renal tubular injury during sickle-cell crisis.Screening for chronic kidney disease in HIV-infected patients.Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.Renal recovery Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.Association of urinary injury biomarkers with mortality and cardiovascular events.Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN The use of targeted biomarkers for chronic kidney disease.Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures Association between plasma neutrophil gelatinase associated lipocalin level and obstructive sleep apnea or nocturnal intermittent hypoxia Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus CKD273, a new proteomics classifier assessing CKD and its prognosis Green tea polyphenols stimulate mitochondrial biogenesis and improve renal function after chronic cyclosporin a treatment in rats Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis.NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why.Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human.Urinary biomarkers at early ADPKD disease stage Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy.

P2860

Q24320230-A77C125C-F357-4B72-8C8C-ACAB977F851E Q26799505-6D5AC863-0015-46C3-AA83-9D3EDDD54A72 Q26853272-36608478-3ED7-4293-8243-CE732E6F7A3B Q26853698-4C08965E-025D-4F0F-810E-EB691D12DCC2 Q26861451-AA6C0155-15EE-4FAB-9A4C-F4A1E43B9267 Q27007027-C7C536D3-7509-4F49-9840-0DE720B7B9D7 Q28087304-4D4C7D1A-F756-4BE0-96A0-2E9C4ED35FB9 Q30391513-6DA6526A-0D6A-4841-95FE-F6CD95621B2E Q30423005-DBA0CDD5-D644-49AF-9585-5AF6F7A4FF99 Q30590366-4DE55E51-02C5-4FF8-A26E-7C5A3901E348 Q30879334-6389F1B7-B875-4DA6-9BAB-EEB0612235A9 Q33553300-F59B59C6-6071-484A-BA10-F282F202E664 Q33639802-A4837945-E63F-4C7F-9870-CB917012C2C1 Q33684220-BB0F9595-D8F0-4C5C-839C-1A319B254946 Q33734661-F55782DE-7662-4EBB-A930-A253C0724F46 Q33750273-00CA30C5-EF51-43E4-9844-6A4C0D5C7B30 Q33754152-24184B99-F8CE-4791-BE52-86185A8BB7EF Q33814882-A29672E7-06E6-4505-B26D-5B310B3DFA47 Q33844617-53B7C208-F0DA-4EA4-986C-EEE1E03651B7 Q33945154-79C7BE26-5EA1-4986-8669-36B20D0DCAB6 Q33995274-4CD7A90A-2691-4362-8C33-76296AA9238D Q34346928-5A10C4F8-0E2C-4859-9E97-47E05309BD45 Q34501874-34C9A38F-394E-48A7-A5DE-BD5A1C3B45AB Q34523585-FAD7AF57-239B-4B02-8091-568C0753EC89 Q34559205-7962E0D2-4C57-4DDB-A84A-ACD8BD2DD5BE Q34644160-1F40FE1D-8B9C-42BB-8390-96B6CE1FAF62 Q34729912-F3B8308F-E720-4296-BC5D-8399BAF73FB4 Q34766031-965E862D-7516-4AC5-A0B2-6B0DCBB924A6 Q34825843-B17E8D0E-F57B-40F5-B4E9-F769A31827E7 Q34997491-2402DF31-1B59-4B2E-9207-DB67A333AB6C Q35017352-88BCF773-58AA-4C10-AA0A-5484DC06FEA3 Q35064410-F52F6012-B837-481D-8CD7-C92C82DE5259 Q35076289-B31A4583-3B03-4751-9797-866F3A455F4D Q35188531-4F100978-60DE-47EB-AC88-12C2046E296A Q35269939-9F1E3AA1-FECF-427C-9D49-D570E99779DC Q35392624-B6E46A6E-311B-4EAF-8C19-ADD12D56EED7 Q35547961-870FCE59-321A-4444-91EA-B9F3B11C25D1 Q35626252-614EAE9A-32C1-44F8-8B55-11D72190B988 Q35626257-979AE579-AA58-4601-89CF-F242A19DF6F7 Q35674267-9B8321A3-4378-4476-8A38-17307813438D

P2860

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

http://www.wikidata.org/entity/Q37087937

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neutrophil gelatinase-associat ...... ion of chronic kidney disease.

@en

type

label

Neutrophil gelatinase-associat ...... ion of chronic kidney disease.

@en

prefLabel

Neutrophil gelatinase-associat ...... ion of chronic kidney disease.

@en

P1433

Q37087937-07E80CCF-3D44-425D-AF75-DC7EC11D5844

P1476

Q37087937-6B0602D3-C224-47F2-8FD1-77DE73B4A8FE

P2093

Q37087937-36D1DE74-69D9-4994-99A9-A00C8263167D

Q37087937-98FBDA99-E94D-44C0-A378-1A06854FCADA

Q37087937-B3E0E281-6D9B-4463-91B8-B5D4E6672134

Q37087937-D94CF138-10BF-4456-98DF-C8C1C272CE0D

Q37087937-FD5C0163-F99C-4C27-B9DB-ADDA57D6851F

P2860

Q37087937-07015683-6536-4A84-B0E6-84DEB19896B3

Q37087937-0709DEF6-7E6A-4DC6-A41E-E9FD01ECB875

Q37087937-1A4EAB26-5745-40EA-BE3E-BAD65238FC26

Q37087937-1E4A2E5A-B5B6-42A4-8E21-7ED8BD08E570

Q37087937-20EEA0F3-F421-4CCF-B99E-6B53E6A93400

Q37087937-32C8ECD0-668B-419F-9D4A-DCFCAE9DA5AE

Q37087937-5572F893-5090-442F-96CF-5108A8E1E9B3

Q37087937-64AFAC24-EC0E-4336-8170-ADFFDCC89439

Q37087937-6A34F683-5122-4B87-86BC-410C1282E9EC

Q37087937-6F6E8E51-325D-418D-8BF9-19846FCC5874

P304

Q37087937-ED7AB800-ABC0-4DDF-9C29-64362978CA90

P31

Q37087937-C8C65CE6-ECB6-448B-A48A-6D4C78665673

P356

Q37087937-7A944197-8C79-4969-8771-76D101A2E511

P433

Q37087937-2112CEA9-2942-45DC-99B2-E6871B2E5846

P478

Q37087937-E43B246D-F225-4366-968B-7CAFC149F028

P50

Q37087937-146C6A96-B33D-4B7F-A603-85AA85882028

Q37087937-31D4FFDC-71B8-4487-AC9E-F5591CE6CA92

Q37087937-8917AD70-2BF9-47C5-9AD7-91BBFCC17A2B

P577

Q37087937-01F73267-CC06-4F76-A3DE-095971A8D5BE

P5875

Q37087937-EC953D83-874B-4A02-87CF-71C87DF91DFE

P698

Q37087937-77C1CE34-AA04-4A73-BDED-44122A231187

P932

Q37087937-C9BB6017-1D37-4E0E-BEEB-B25A4F4904A4

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Neutrophil gelatinase-associat ...... sion of chronic kidney disease

@en

P2093

Giacomo Nicocia

http://www.w3.org/2001/XMLSchema#string

Maria Rosaria Fazio

http://www.w3.org/2001/XMLSchema#string

Michele Buemi

http://www.w3.org/2001/XMLSchema#string

Susanna Campo

http://www.w3.org/2001/XMLSchema#string

Valentina Donato

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of chronic kidney disease in the United States

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.

The role of renal proximal tubular cells in diabetic nephropathy.

Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage.

Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.

Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.

Endothelin: a mediator of renal disease progression.

The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

P304

337-344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03530708

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Davide Bolignano

Giuseppe Coppolino

Antonio Lacquaniti

P577

2009-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23957065

http://www.w3.org/2001/XMLSchema#string

P698

19176795

http://www.w3.org/2001/XMLSchema#string

P932

2637601

http://www.w3.org/2001/XMLSchema#string